HER2-positive metastatic breast cancer with brain metastases responds favorably to pyrotinib and trastuzumab-based treatment: A case report and literature review

Overview of attention for article published in Frontiers in oncology, January 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (52nd percentile)
Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 13 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 28,887 followers.

HER2-positive metastatic breast cancer with brain metastases responds favorably to pyrotinib and trastuzumab-based treatment: A case report and literature review https://t.co/6fMCNE5AfX https://t.co/vurK8BX0Av

20 Jan 2023

Reply Repost Favourite

New research: HER2-positive metastatic breast cancer with brain metastases responds favorably to pyrotinib and trastuzumab-based treatment: A case report and literature review: For HER2-positive metastatic breast cancer patients with the brain… https://t.c

19 Jan 2023

Reply Repost Favourite

RT @gedefo_sefh: HER2-positive metastatic breast cancer with brain metastases responds favorably to pyrotinib and trastuzumab-based treatme…

19 Jan 2023

Reply Repost Favourite

HER2-positive metastatic breast cancer with brain metastases responds favorably to pyrotinib and trastuzumab-based treatment: A case report and literature review https://t.co/dHZMBzjatf

19 Jan 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.